Viking Scientific, Inc

Neurocrine Biosciences, headquartered in San Diego, is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Incorporated in 1992, its products address some of the largest pharmaceutical markets in the world, including insomnia, female and male disorders, anxiety, depression, diabetes, irritable bowel syndrome, eating disorders, pain, and autoimmunity. The company s research group focuses on developing small molecule compounds against G-protein coupled receptors and clinical development. One of its business strategies is to utilize strategic alliances to enhance its development and commercialization capabilities. Neurocrine Biosciences has alliances with various pharmaceutical companies, including Pfizer, GlaxoSmithKline, Wyeth, and Eli Lilly and Company.

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing technology to fuel drug discovery and clinical development of treatments for central nervous system disorders. It has five drug programs in clinical and pre-clinical development directed at large unmet medical needs and major commercial markets. ACADIA s three Phase II-stage clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, ACP-103 as an adjunctive therapy for schizophrenia and ACP-104 for treatment of schizophrenia. The company also has clinical and pre-clinical development programs in the areas of neuropathic pain and glaucoma in collaboration with Allergan. ACADIA maintains headquarters and biology research facilities in San Diego and a chemistry research facility in Malmo, Sweden. It trades on NASDAQ under the symbol ACAD.

Sta Pharmaceutical, with locations in Shanghai, Tianjin, Wuhan, Chengdu, and Changzhou, is a leading pharmaceutical company specializing in small molecule API process development, formulation development and manufacturing, as well as oligonucleotide and peptide discovery and development. With state-of-the-art R&D labs and a fully integrated R&D and manufacturing campus, Sta Pharmaceutical offers a comprehensive range of services from preclinical to commercial manufacturing, providing efficient and high-quality solutions to global pharma and biotech customers. With a focus on delivering innovative medicinal chemistry solutions, Sta Pharmaceutical utilizes its discovery chemistry platform to create, identify, and support the discovery of preclinical candidates. The company also offers custom synthesis solutions for various molecules, including amidite, GalNAc, unnatural amino acids, and other peptide-related building blocks, to accelerate therapeutic development. With its expertise and capabilities, Sta Pharmaceutical is committed to advancing the pharmaceutical industry and meeting the needs of its clients.Generated from the website